Also trades as: PFE.TO (TSX) · $vol 1M · PFE.F (FSX) · $vol 1M · PFE.DE (XETRA) · $vol 1M · PFE.NE (NEO) · $vol 1M · PFE.BA (BUE) · $vol 0M
PFE NYSE
Pfizer Inc.
1W: +1.2%
1M: +3.9%
3M: +18.0%
YTD: +20.3%
1Y: +22.9%
3Y: +10.2%
5Y: -10.7%
$29.73
-0.06 (-0.20%)
Weekly Expected Move ±2.9%
$28
$29
$30
$31
$32
Credit Risk of going bust: lower than 82% of companies Debt: 27.1% of company value Bonds: $1.15B held by 485 funds, 62 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.54 (down 98%), Pfizer Inc. would be worth roughly what it owes.
Total debt $63.19B against a stock market value of $169.79B.
Distance to default 10.27 (Merton model): prices to 2026-10-26, balance sheet 2026-06-28, debt counted $32.95B (short-term plus half of long-term), stock volatility 21.2%; Altman Z 2.14. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $0.54 (down 98%), Pfizer Inc. would be worth roughly what it owes.
Total debt $63.19B against a stock market value of $169.79B.
Distance to default 10.27 (Merton model): prices to 2026-10-26, balance sheet 2026-06-28, debt counted $32.95B (short-term plus half of long-term), stock volatility 21.2%; Altman Z 2.14. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.54
Bullish
6 bullish
4 neutral
0 bearish
Articles (24h)
10
Hourly Sentiment (24h)
Articles (9)
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now
Buy, Hold or Sell ABBV Stock? Key Tips Ahead of Q3 Earnings
Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
3 Dirt Cheap Dividend Stocks to Buy Hand Over Fist
4 stocks to watch on Tuesday: DASH, SOFI, BA, and PFE
Pfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Pfizer posts late-stage trial win for multiple myeloma drug Elrexfio in an earlier line setting
Pfizer Talzenna/Xtandi combo approved for earlier prostate cancer setting
0.52
Bullish
15 bullish
8 neutral
1 bearish
Articles (7d)
24
Daily Sentiment (7 Days)
Articles (100)
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now
Buy, Hold or Sell ABBV Stock? Key Tips Ahead of Q3 Earnings
Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
3 Dirt Cheap Dividend Stocks to Buy Hand Over Fist
4 stocks to watch on Tuesday: DASH, SOFI, BA, and PFE
Pfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Pfizer posts late-stage trial win for multiple myeloma drug Elrexfio in an earlier line setting
Pfizer Talzenna/Xtandi combo approved for earlier prostate cancer setting
Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?
Celcuity says Revtorpyk boosts progression-free survival in breast cancer
Biogen Q3 Preview: Will Growth Products Drive an Earnings Beat?
Pfizer sees strong response for pediatric pneumonia vaccine in mid-stage trial
Pfizer's Dividend Yield Is One of the Highest in the S&P 500. Here's Why the Dividend Is Safer Than It Might Seem
Better Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb?
What Higher Interest Rates Mean for Dividend Stocks Like AbbVie and Pfizer
Bristol Myers Squibb vs. Pfizer: Consistency vs. Scale in Revenue
Centene, Harmony Biosciences lead list of undervalued healthcare stocks
Keytruda, Padcev combo for bladder cancer approved by European Commission
Can BMY Navigate Generic Challenges Across Its Key Drug Portfolio?
Moderna's Respiratory Portfolio Expands: Can It Reduce COVID Reliance?
Forget COVID: Moderna Is Turning Into a Cancer Company -- and Wall Street Is Taking Notice
Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing
XLV touches a new high, hitting overbought territory
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Pfizer's Stock Is Finally Showing Signs of Life. Could This Be the Start of a Much Bigger Rally?
Roche pauses German investments over healthcare reforms
Pfizer's Non-Oncology Performance in Q3: Driving Factors to Watch
Intercontinental Exchange's NYSE extends trading hours for NYSE American options
Can Lifyorli Aid Corcept's Long-Term Growth Prospects Beyond Korlym?
Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy?
Warren Buffett's Market Warning Is Hard to Ignore. But I'd Buy These 3 Stocks Anyway.
Here's What $10,000 in Each of These 5 High-Yield Dividend Stocks Could Pay You in a Year
Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead?
Here's How Many Shares of AbbVie You'd Need for $5,000 in Yearly Dividends
Pfizer Just Declared Its 352nd Straight Quarterly Dividend. Is the 6% Yield Safe?
Lilly, Pfizer, J&J among winners of EU drug recommendations this month
6 Blue Chip Stocks Trading Well Below Their Highs
2 High-Yield Dividend Stocks Worth Buying Before 2026 Ends
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Cboe plans to extend options trading hours for major stocks and ETFs - report
Pfizer (PFE) Gains As Market Dips: What You Should Know
IDEAYA resumed at Buy at Stifel on combo treatment for uveal melanoma
Forget Treasury Bonds: This 6%-Yielding Pharma Stock Pays You to Wait for Its Pipeline
MRNA Stock Gains Over $4B in a Week: Time to Buy, Hold or Sell?
Roivant Sciences added to Citi's 90-day catalyst watch
Reasons Why Investors Should Consider Betting on Arvinas Stock
Johnson & Johnson vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
BMY Surges 35.7% in a Year: Should You Buy, Sell or Hold the Stock?
Pfizer Moves Past 50-Day SMA: Time to Buy, Hold or Exit the Stock?
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends?
Hospital group files lawsuit to stop 340B rebate pilot again
Alnylam vs. Ionis: Here's the Better Bad-News Buy
Pfizer Inc. $PFE Holdings Raised by GAMMA Investing LLC
Top Research Reports for JPMorgan, ASML & Chevron
Cancer Stocks to Consider as Oncology Innovation Accelerates
Roche Gets FDA Approval for Another Label Expansion of Tecentriq
Dividend Roundup: Starbucks, Pfizer, Micron, AbbVie, and more
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
Pfizer Inc. $PFE Shares Sold by Sapient Capital LLC
Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
2 Growth Stocks to Buy in October
NVS Wins FDA Nod for Label Expansion of Immunology Drug Rhapsido
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?
Pfizer's Oncology Outlook: Key Drivers to Watch Ahead of Q3 Results
FDA Backs PFE's Tukysa Combo in Front-Line Maintenance Breast Cancer
Pfizer Trades Under 10 Times Forward Earnings With a Yield Near 6%. Here's What History Says Happens Next.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
How Is Eli Lilly's Oncology Portfolio Poised Ahead of Q3 Earnings?
Pfizer to close penicillin unit, cut around 330 jobs in Italy
Pfizer Stock: Buy, Sell, or Hold?
Pfizer’s Tukysa regimen approved in U.S. for front-line breast cancer
Pharma lobby group sues Trump administration over MFN pricing
Warren Buffett's Favorite Valuation Indicator Blew Past the Level He Warned Was "Playing With Fire." Here Are 3 Stocks Still Cheap Enough to Buy.
State attorneys general sue RFK Jr., seeking to reinstate childhood vaccine schedule
3 of the Best Dividend Stocks to Buy in October 2026
Eli Lilly-backed TRex Bio targets up to $133M in U.S. IPO
PFE vs. JNJ: Which Stock Is the Better Value Option?
AbbVie's Epcoritamab Combo Shows PFS Benefit in Frontline DLBCL
Pfizer declares $0.43 dividend
Are Investors Undervaluing Pfizer (PFE) Right Now?
Why Pfizer Might Be the Most Underrated Dividend Stock to Buy Right Now
What's next for personalized mRNA cancer vaccines?
Argent Capital Management LLC Purchases New Holdings in Pfizer Inc. $PFE
Pfizer vs. J&J: Comparing Growth, Patent Risks and Valuation
Vaxcyte jumps on phase 3 data for pneumonia vaccine VAX-31
SMMT Inks Deal With AZN-Daiichi to Study Ivonescimab + Datroway Combos
Eli Lilly vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Got $10,000 to Invest in October? These Stocks Could Generate Over $634 in Annual Income.
Better High-Yield Dividend Stock: Pfizer or Novo Nordisk?
Here's Exactly Why I'm Not Afraid of Pfizer's 6% Dividend Yield
Notable healthcare headlines for the week: Pfizer, Sanofi, and Novartis in focus
3 Dirt Cheap Dividend Stocks Worth Buying in October
My 3 Favorite Ultra-High-Yield Dividend Stocks to Buy for October
AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot
3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note
Bristol Myers Squibb Now Trades at Only 9.4X Forward Earnings -- Is This Value Stock a Buy?
Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Pfizer says phase 3 data buoys Litfulo as a vitiligo treatment